novo nordisk glp-1 weight loss Eli Lilly set to leapfrog in weight-loss drug race US FDA says lowest dose

While challenges with adherence, side effects, and weight regain upon discontinuation have prompted the search for additional strategies, targets like GLP-1R, GIPR, and GDF8 (Myostatin) still remain the most highly relevant and active areas of research for developing effective obesity treatments

This isn't surprising given that this was the first company to bring a tubeless insulin delivery device to market back in 2006

Unintentional weight loss means losing weight without trying

Michigan's largest health insurer, Blue Cross Blue Shield of Michigan, is stopping coverage for glucagon-like peptide-1 (GLP-1) drugs used for weight loss starting in January 2025

That changed when I started using HIMIYER GLP - 1SIX IN-ONE Health Solution Oral Liquid